Cargando…
Rituximab therapy in Greek patients with rheumatoid arthritis
OBJECTIVE: An open-label, prospective, uncontrolled study created to investigate clinical response, serological changes and side effects in Greek patients with rheumatoid arthritis (RA), after B-cell depletion with rituximab. METHODS: Patients with high disease activity (disease activity score [DAS]...
Autores principales: | Tsiakalos, Aristotelis P, Avgoustidis, Nestor K, Moutsopoulos, Haralampos M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727907/ https://www.ncbi.nlm.nih.gov/pubmed/19707469 |
Ejemplares similares
-
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
por: Bertsias, Antonios, et al.
Publicado: (2022) -
Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015) -
Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007) -
Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022) -
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
por: Mishra, Richa, et al.
Publicado: (2009)